Recently, Hilgenfeld and co-workers reported (Science 2020, 368, 409–412) that alpha-ketoamide-derived substrates act as inhibitors of COVID by targeting the SARS-CoV-2 main protease. Their crystal structure analysis provided the basis for an in-depth computational study by Albert Poater, Serra Hunter fellow at IQCC (Univ. Girona). His calculations based on Density Functional Theory provided the origin